BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26484611)

  • 1. Unpredictable changes of selected miRNA in expression profile of HNSCC.
    Lamperska KM; Kozlowski P; Kolenda T; Teresiak A; Blizniak R; Przybyla W; Masternak MM; Golusinski P; Golusinski W
    Cancer Biomark; 2016; 16(1):55-64. PubMed ID: 26484611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
    Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
    PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
    Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
    Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low let-7d and high miR-205 expression levels positively influence HNSCC patient outcome.
    Kolenda T; Guglas K; Teresiak A; Bliźniak R; Lamperska K
    J Biomed Sci; 2019 Feb; 26(1):17. PubMed ID: 30755200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
    Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
    Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
    Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
    Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.
    Childs G; Fazzari M; Kung G; Kawachi N; Brandwein-Gensler M; McLemore M; Chen Q; Burk RD; Smith RV; Prystowsky MB; Belbin TJ; Schlecht NF
    Am J Pathol; 2009 Mar; 174(3):736-45. PubMed ID: 19179615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
    Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
    Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
    Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T
    Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
    Kimura S; Naganuma S; Susuki D; Hirono Y; Yamaguchi A; Fujieda S; Sano K; Itoh H
    Oncol Rep; 2010 Jun; 23(6):1625-33. PubMed ID: 20428818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel saliva-based microRNA biomarker panel to detect head and neck cancers.
    Salazar C; Nagadia R; Pandit P; Cooper-White J; Banerjee N; Dimitrova N; Coman WB; Punyadeera C
    Cell Oncol (Dordr); 2014 Oct; 37(5):331-8. PubMed ID: 25156495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four PTEN-targeting co-expressed miRNAs and ACTN4- targeting miR-548b are independent prognostic biomarkers in human squamous cell carcinoma of the oral tongue.
    Berania I; Cardin GB; Clément I; Guertin L; Ayad T; Bissada E; Nguyen-Tan PF; Filion E; Guilmette J; Gologan O; Soulieres D; Rodier F; Wong P; Christopoulos A
    Int J Cancer; 2017 Dec; 141(11):2318-2328. PubMed ID: 28779483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation.
    Severino P; Brüggemann H; Andreghetto FM; Camps C; Klingbeil Mde F; de Pereira WO; Soares RM; Moyses R; Wünsch-Filho V; Mathor MB; Nunes FD; Ragoussis J; Tajara EH
    BMC Cancer; 2013 Nov; 13():533. PubMed ID: 24209638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients.
    Summerer I; Unger K; Braselmann H; Schuettrumpf L; Maihoefer C; Baumeister P; Kirchner T; Niyazi M; Sage E; Specht HM; Multhoff G; Moertl S; Belka C; Zitzelsberger H
    Br J Cancer; 2015 Jun; 113(1):76-82. PubMed ID: 26057452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profiles of miR-29c, miR-200b and miR-375 in tumour and tumour-adjacent tissues of head and neck cancers.
    Hudcova K; Raudenska M; Gumulec J; Binkova H; Horakova Z; Kostrica R; Babula P; Adam V; Masarik M
    Tumour Biol; 2016 Sep; 37(9):12627-12633. PubMed ID: 27440205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
    Wong N; Khwaja SS; Baker CM; Gay HA; Thorstad WL; Daly MD; Lewis JS; Wang X
    Cancer Med; 2016 Jul; 5(7):1619-28. PubMed ID: 27109697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA profile in site-specific head and neck squamous cell cancer.
    Kalfert D; Pesta M; Kulda V; Topolcan O; Ryska A; Celakovsky P; Laco J; Ludvikova M
    Anticancer Res; 2015 Apr; 35(4):2455-63. PubMed ID: 25862914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miRNA is a novel marker for head and neck squamous cell carcinoma.
    Hsu CM; Lin PM; Wang YM; Chen ZJ; Lin SF; Yang MY
    Tumour Biol; 2012 Dec; 33(6):1933-42. PubMed ID: 22811001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Study on the Correlations of the miR-31 Expression with the Pathogenesis and Prognosis of Head and Neck Squamous Cell Carcinoma.
    Qiang H; Zhan X; Wang W; Cheng Z; Ma S; Jiang C
    Cancer Biother Radiopharm; 2019 Apr; 34(3):189-195. PubMed ID: 30628842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of miR-146a and miR-155 in blood, tissue and cell lines of head and neck squamous cell carcinoma patients and their impact on cell proliferation and migration.
    Lerner C; Wemmert S; Bochen F; Kulas P; Linxweiler M; Hasenfus A; Heinzelmann J; Leidinger P; Backes C; Meese E; Urbschat S; Schick B
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):757-66. PubMed ID: 26621153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.